- Home
- / Day One Biopharmaceuticals
Day One Biopharmaceuticals
Stock Price
$14.4
2024-10-29
Market Capitalization
$1.4 B
2024-10-29
Revenue
$158.2 M
FY, 2025
Day One Biopharmaceuticals Summary
Company Summary
- Overview
- Day One Biopharmaceuticals is a company that develops drugs and therapies for cancer treatment. The company develops new insights from the biology of pediatric cancer and new therapies that meet the critical needs of people of all ages living with cancer.
- Type
- Public
- Status
- Active
- Founded
- 2018
- HQ
- South San Francisco, CA, US | view all locations
- Website
- https://dayonebio.com/
- Cybersecurity rating
Table of Contents
Key People
Lisa Bowers, Chief Commercial Officer
Mike Preigh, Chief of Technology Operations
Davy Chiodin, Chief Development Officer
LocationsView all
1 location detected
South San Francisco, CA HQ
United States
395 Oyster Point Blvd Suite 217
Day One Biopharmaceuticals Financials
Summary Financials
- Revenue (FY, 2025)
- $158.2M
- Net income (FY, 2025)
- ($107.3M)
- Cash (FY, 2025)
- $197.1M
- EBIT (FY, 2025)
- ($127.8M)
- Enterprise value
- $1.2B